FR2053025A1 - - Google Patents

Info

Publication number
FR2053025A1
FR2053025A1 FR7023574A FR7023574A FR2053025A1 FR 2053025 A1 FR2053025 A1 FR 2053025A1 FR 7023574 A FR7023574 A FR 7023574A FR 7023574 A FR7023574 A FR 7023574A FR 2053025 A1 FR2053025 A1 FR 2053025A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7023574A
Other languages
French (fr)
Other versions
FR2053025B1 (cg-RX-API-DMAC10.html
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck & Cie
Merck and Co Inc
Original Assignee
Merck & Cie
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Cie, Merck and Co Inc filed Critical Merck & Cie
Publication of FR2053025A1 publication Critical patent/FR2053025A1/fr
Application granted granted Critical
Publication of FR2053025B1 publication Critical patent/FR2053025B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7023574A 1969-06-25 1970-06-25 Expired FR2053025B1 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83660569A 1969-06-25 1969-06-25
US3029870A 1970-04-20 1970-04-20

Publications (2)

Publication Number Publication Date
FR2053025A1 true FR2053025A1 (cg-RX-API-DMAC10.html) 1971-04-16
FR2053025B1 FR2053025B1 (cg-RX-API-DMAC10.html) 1973-12-21

Family

ID=26705877

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7023574A Expired FR2053025B1 (cg-RX-API-DMAC10.html) 1969-06-25 1970-06-25

Country Status (7)

Country Link
US (2) US3700773A (cg-RX-API-DMAC10.html)
JP (1) JPS4934674B1 (cg-RX-API-DMAC10.html)
CH (1) CH533604A (cg-RX-API-DMAC10.html)
DE (1) DE2031233A1 (cg-RX-API-DMAC10.html)
FR (1) FR2053025B1 (cg-RX-API-DMAC10.html)
GB (1) GB1277153A (cg-RX-API-DMAC10.html)
NL (1) NL7008631A (cg-RX-API-DMAC10.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2192835A1 (cg-RX-API-DMAC10.html) * 1972-07-13 1974-02-15 Sarath
FR2211261A2 (cg-RX-API-DMAC10.html) * 1972-12-26 1974-07-19 Pfizer

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172210A (en) * 1977-06-13 1979-10-23 American Cyanamid Company S-Phenenyltris(sulfonylimino)tri-anionic substituted benzene carboxylic acids
US4143151A (en) * 1978-07-03 1979-03-06 The Dow Chemical Company Method for treating hyperglycemia in mammals using arylamino benzoic acids
US4207330A (en) * 1978-07-03 1980-06-10 The Dow Chemical Company Method for treating hyperglycemia in mammals using arylamino benzoic acids
EP0080609B1 (en) * 1981-11-24 1985-08-21 MEDEA RESEARCH S.r.l. Novel compound having analgesic, antiinflammatory and antipyretic activity, process for its preparation and pharmaceutical compositions containing it
JPS5917276A (ja) * 1982-07-20 1984-01-28 Hitachi Ltd 半導体装置
JPH0660160B2 (ja) * 1985-12-13 1994-08-10 テルモ株式会社 アミド誘導体およびこれを含有する抗アレルギ−剤
DE3713757A1 (de) * 1987-04-24 1988-11-10 Hoechst Ag Benzolsulfonamidderivate und verfahren zu ihrer herstellung
AU5175490A (en) * 1989-02-27 1990-09-26 Du Pont Merck Pharmaceutical Company, The Novel sulfonamides as radiosensitizers
US5545669A (en) * 1994-06-02 1996-08-13 Adams; Jerry L. Anti-inflammatory compounds
US5470882A (en) * 1994-06-02 1995-11-28 Smithkline Beecham Corp. Anti-inflammatory compounds
US6653331B2 (en) * 1996-07-03 2003-11-25 Pharmacia & Upjohn Company Targeted drug delivery using sulfonamide derivatives
AU759255B2 (en) 1998-01-29 2003-04-10 Amgen, Inc. PPAR-gamma modulators
US6583157B2 (en) 1998-01-29 2003-06-24 Tularik Inc. Quinolinyl and benzothiazolyl modulators
US7041691B1 (en) 1999-06-30 2006-05-09 Amgen Inc. Compounds for the modulation of PPARγ activity
US6653332B2 (en) * 2000-05-03 2003-11-25 Tularik Inc. Combination therapeutic compositions and method of use
US20030171399A1 (en) * 2000-06-28 2003-09-11 Tularik Inc. Quinolinyl and benzothiazolyl modulators
AU9233101A (en) * 2000-10-04 2002-04-15 Kissei Pharmaceutical 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
US7223761B2 (en) * 2003-10-03 2007-05-29 Amgen Inc. Salts and polymorphs of a potent antidiabetic compound
US6806291B1 (en) * 2003-10-09 2004-10-19 The Foundation For The Lsu Health Sciences Center Analgesic compounds, their synthesis and pharmaceutical compositions containing them
CA2555914A1 (en) * 2004-03-08 2005-09-22 Amgen Inc. Therapeutic modulation of ppar (gamma) activity
WO2017153952A1 (en) * 2016-03-10 2017-09-14 Glaxosmithkline Intellectual Property Development Limited 5-sulfamoyl-2-hydroxybenzamide derivatives

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2103522A (en) * 1936-12-03 1937-12-28 Farastan Company Therapeutic composition
US2852557A (en) * 1954-04-09 1958-09-16 Schenley Ind Inc 4-sulfonyl derivatives of salicylic acid

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2103522A (en) * 1936-12-03 1937-12-28 Farastan Company Therapeutic composition
US2852557A (en) * 1954-04-09 1958-09-16 Schenley Ind Inc 4-sulfonyl derivatives of salicylic acid

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2192835A1 (cg-RX-API-DMAC10.html) * 1972-07-13 1974-02-15 Sarath
FR2211261A2 (cg-RX-API-DMAC10.html) * 1972-12-26 1974-07-19 Pfizer

Also Published As

Publication number Publication date
FR2053025B1 (cg-RX-API-DMAC10.html) 1973-12-21
NL7008631A (cg-RX-API-DMAC10.html) 1970-12-29
CH533604A (de) 1973-02-15
DE2031233A1 (de) 1971-01-07
US3674843A (en) 1972-07-04
GB1277153A (en) 1972-06-07
JPS4934674B1 (cg-RX-API-DMAC10.html) 1974-09-17
US3700773A (en) 1972-10-24

Similar Documents

Publication Publication Date Title
AU2270770A (cg-RX-API-DMAC10.html)
FR2053025B1 (cg-RX-API-DMAC10.html)
CS152345B2 (cg-RX-API-DMAC10.html)
AU465452B2 (cg-RX-API-DMAC10.html)
AU429630B2 (cg-RX-API-DMAC10.html)
AU2355770A (cg-RX-API-DMAC10.html)
AU5712069A (cg-RX-API-DMAC10.html)
AU417208B2 (cg-RX-API-DMAC10.html)
AU5113869A (cg-RX-API-DMAC10.html)
AU442285B2 (cg-RX-API-DMAC10.html)
AU442535B2 (cg-RX-API-DMAC10.html)
AU428129B2 (cg-RX-API-DMAC10.html)
AU470661B1 (cg-RX-API-DMAC10.html)
AU442357B2 (cg-RX-API-DMAC10.html)
AT308690B (cg-RX-API-DMAC10.html)
AU428074B2 (cg-RX-API-DMAC10.html)
AU442554B2 (cg-RX-API-DMAC10.html)
AU410358B2 (cg-RX-API-DMAC10.html)
AU442380B2 (cg-RX-API-DMAC10.html)
AU442322B2 (cg-RX-API-DMAC10.html)
AU438128B2 (cg-RX-API-DMAC10.html)
AU425297B2 (cg-RX-API-DMAC10.html)
AU6254169A (cg-RX-API-DMAC10.html)
AU6261969A (cg-RX-API-DMAC10.html)
AU5979569A (cg-RX-API-DMAC10.html)

Legal Events

Date Code Title Description
ST Notification of lapse